Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
FOSTER, N; Cunnama, L; McCarthy, K; Ramma, L; Siapka, M; Sinanovic, E; Churchyard, G; FIELDING, K; GRANT, AD; Cleary, S;
2021
PLOS ONE, (2021).16 5 10.1371/journal.pone.0251547.
Latent Tuberculosis Infection Status of Pregnant Women in Uganda Determined Using QuantiFERON TB Gold-Plus.
Bongomin, F; Ssekamatte, P; Nattabi, G; Olum, R; Ninsiima, S; Kyazze, AP; Nabakka, W; Kukunda, R; COSE, S; KIBIRIGE, D; Batte, C; Kaddumukasa, M; Kirenga, BJ; Nakimuli, A; Baluku, JB; Andia-Biraro, I;
2021
Open forum infectious diseases, (2021).8 6 10.1093/ofid/ofab241.
Health system influences on the implementation of tuberculosis infection prevention and control at health facilities in low-income and middle-income countries: a scoping review.
Zwama, G; Diaconu, K; Voce, AS; O'May, F; GRANT, AD; Kielmann, K;
2021
BMJ Global Health, (2021).6 5 10.1136/bmjgh-2020-004735.
Characteristics and Comorbidities at Start of Tuberculosis Treatment in Three Regions of the Philippines: The St-ATT Cohort.
COX, S; EDWARDS, T; Faguer, B; Ferrer, J; Suzuki, S; Koh, M; Ferdous, F; Saludar, N; Garfin, A-MC; Castro, MC; Solon, J;
2021
PLoS Global Public Health, (2021).1 11 10.2139/ssrn.3834106.
Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease.
Pollara, G; Turner, CT; Rosenheim, J; Chandran, A; Bell, LC K; Khan, A; Patel, A; Peralta, LF; Folino, A; Akarca, A; Venturini, C; Baker, T; Ecker, S; Ricciardolo, FL M; Marafioti, T; Ugarte-Gil, C; MOORE, DA J; Chain, BM; Tomlinson, GS; Noursadeghi, M;
2021
SCIENCE TRANSLATIONAL MEDICINE, (2021).13 592 10.1126/scitranslmed.abg7673.
Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses.
Nymark, LS; Miller, A; VASSALL, A;
2021
PharmacoEconomics - open, (2021).5 4 10.1007/s41669-021-00269-4.
Digital adherence technology for TB: focus on livelihoods as well as lives.
MCQUAID, CF; FOSTER, N; QUAIFE, M; Levy, J; TADESSE, AW; Charalambous, S; Alacapa, JV; Deyanova, N; Mganga, A; HOUBEN, RM G J; FIELDING, KL;
2021
International journal of tuberculosis and lung disease, (2021).25 5 10.5588/ijtld.21.0070.
Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries.
Estill, J; Islam, T; HOUBEN, RM G J; Rudman, J; Ragonnet, R; McBryde, ES; Trauer, JM; Orel, E; Nguyen, AT; Rahevar, K; Morishita, F; Oh, KH; Raviglione, MC; Keiser, O;
2021
The Lancet Regional Health - Western Pacific, (2021).11, 10.1016/j.lanwpc.2021.100147.
Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.
CALDERWOOD, CJ; Wilson, JP; FIELDING, KL; Harris, RC; Karat, AS; MANSUKHANI, R; FALCONER, J; Bergstrom, M; Johnson, SM; MCCREESH, N; MONK, EJ M; Odayar, J; Scott, PJ; Stokes, SA; Theodorou, H; MOORE, DA J;
2021
PLoS medicine, (2021).18 4 10.1371/journal.pmed.1003566.
Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone.
Nadarajan, D; Hillemann, D; Kamara, R; Foray, L; Conteh, OS; Merker, M; Niemann, S; Lau, J; Njoya, M; KRANZER, K; Somoskovi, A; Maurer, FP;
2021
Journal of clinical microbiology, (2021).59 5 10.1128/JCM.02983-20.